CEREBRAL INFARCTION
Clinical trials for CEREBRAL INFARCTION explained in plain language.
Never miss a new study
Get alerted when new CEREBRAL INFARCTION trials appear
Sign up with your email to follow new studies for CEREBRAL INFARCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could early aspirin after stroke save more brains?
Disease control Not yet recruitingThis study tests whether giving a low-dose aspirin just 2 hours after clot-busting treatment for stroke is safer and more effective than waiting the standard 24 hours. About 210 adults aged 18-65 with acute ischemic stroke will be randomly assigned to early or standard aspirin ti…
Matched conditions: CEREBRAL INFARCTION
Phase: PHASE4 • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope for late-arriving stroke patients: MRI-guided drug trial aims to restore independence
Disease control Not yet recruitingThis study tests whether the drug tirofiban can help people who had a stroke more than 24 hours ago but within 7 days. It uses a special MRI scan to pick the right patients. About 458 adults will take part to see if the drug improves recovery and daily function.
Matched conditions: CEREBRAL INFARCTION
Phase: PHASE3 • Sponsor: Weifang Medical University • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New drug aims to protect brain after stroke clot removal
Disease control Not yet recruitingThis early-stage study tests the safety of a drug called EMPAVELI in 20 adults who had a stroke from a large blood clot and already had it removed. The drug is given through a pump shortly after the procedure and again at 24 and 48 hours to reduce swelling and inflammation when b…
Matched conditions: CEREBRAL INFARCTION
Phase: PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated May 18, 2026 12:09 UTC